American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research

NEW YORK (PRWEB) MARCH 13, 2018 – The American Liver Foundation (ALF), the nation’s largest patient advocacy organization for people with liver disease, announced today the launch of an online…

Continue Reading American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research
Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?
Source: Pixabay

Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?

The Southern Daily Echo originally reported that a majority of pancreatic cancer patients don't receive life-extending treatment after diagnosis. Recently, the Pancreatic Cancer UK charity reported that only a small…

Continue Reading Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?
A Drug That Can Mimic Exercise May Be Closer Than You Thought
Source: Pixabay

A Drug That Can Mimic Exercise May Be Closer Than You Thought

Scientists in California at Salk Institute for Biological Studies are currently developing a drug that can mimic the effects in the body usually obtained from exercise, reports the National Post.…

Continue Reading A Drug That Can Mimic Exercise May Be Closer Than You Thought
A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy
source: pixabay.com

A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy

CRISPR gene editing technology is still mostly in its infancy, but the new tool is already causing a lot of excitement, particularly in the treatment of genetically-linked diseases. A recent…

Continue Reading A CRISPR Gene Editing Technique Could Fix Many of the Mutations Responsible For Duchenne Muscular Dystrophy
These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics
geralt / Pixabay

These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics

According to a story from PressReleasePoint, a new partnership has developed to generate artificial intelligence technology that will help diagnose people with a variety of rare diseases. The partnership consists…

Continue Reading These Organizations Are Joining Forces To Use AI To Develop Improved Rare Disease Diagnostics
A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease
source: pixabay.com

A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease

According to a story from Morningstar, the pharmaceutical company Emerald Health Pharmaceuticals announced that its drug candidate EHP-102 was given Orphan Drug Designation by the U.S Food and Drug Administration…

Continue Reading A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease
Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
source: pixabay.com

Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan

The day after Christmas in 2016 brought a post-Holiday surprise to many in the U.S. with spinal muscular atrophy. December 26, 2016 marked the day that Spinraza was approved by…

Continue Reading Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan